您的购物车当前为空
别名 BAY-2433334, BAY2433334, BAY 2433334, Asundexian
Asundexian (BAY-2433334) 是一种高效且具有口服活性凝血因子 FXIa 抑制剂,可直接且可逆地与FXIa 的活性位点结合,从而抑制其活性。Asundexian 对缓冲液中的人 FXIa 的 IC50 为 1 nM。Asundexian 具有抗肿瘤活性,可用于研究急性缺血性卒中、短暂性脑缺血发作和缺血性卒中。


为众多的药物研发团队赋能,
让新药发现更简单!
Asundexian (BAY-2433334) 是一种高效且具有口服活性凝血因子 FXIa 抑制剂,可直接且可逆地与FXIa 的活性位点结合,从而抑制其活性。Asundexian 对缓冲液中的人 FXIa 的 IC50 为 1 nM。Asundexian 具有抗肿瘤活性,可用于研究急性缺血性卒中、短暂性脑缺血发作和缺血性卒中。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,720 | In stock | |
| 5 mg | ¥ 4,290 | In stock | |
| 10 mg | ¥ 5,970 | In stock | |
| 25 mg | ¥ 8,870 | In stock | |
| 50 mg | ¥ 12,200 | In stock | |
| 100 mg | ¥ 16,300 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 5,290 | In stock |
Asundexian 相关产品
| 产品描述 | Asundexian (BAY-2433334) is a potent and orally active inhibitor of the coagulation factor FXIa that directly and reversibly binds to the active site of FXIa, thereby inhibiting its activity.Asundexian has an IC50 of 1 nM for human FXIa in buffer.Asundexian has antitumor activity and may be useful in studies of Acute ischemic stroke, transient ischemic attack and ischemic stroke. |
| 靶点活性 | FXIa (human):1 nM |
| 体内活性 | Asundexian 在人体和兔子的血浆中体外展现出强大的抗凝活性,并在兔子动脉血栓模型中体内显示出抗血栓疗效。[1] |
| 别名 | BAY-2433334, BAY2433334, BAY 2433334, Asundexian |
| 分子量 | 592.93 |
| 分子式 | C26H21ClF4N6O4 |
| CAS No. | 2064121-65-7 |
| Smiles | CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(cc1=O)-c1cc(Cl)ccc1-n1cc(nn1)C(F)(F)F |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 118.59 mg/mL (200.01 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容